September 18 - 20, 2013
Explore innovative models for advancing the translation of novel neurotechnologies, such as neurostimulation, brain-computer interfaces, and neuron replacement therapies, into diagnostic tools and treatments for neurological and psychiatric disease.
Thursday, May 23, 2013 | 7:00 PM - 8:30 PM
Speakers: Steve Ettlinger (Author), Dwight Eschliman (Photographer), J. Kenji Lopez-Alt (Serious Eats)
Moderator: Dan Pashman (Journalist)
Whether it's mined from deep in the earth or grown on a farm, the ingredients in modern food have to come from somewhere. Join us as we learn just where some of the ingredients in your favorite snacks come from and just how combining certain elements can lead to either a food fantasy or fatal fare! Part of the Science and the Seven Deadly Sins Series.
Friday, May 17, 2013 | 8:00 AM - 4:30 PM
Speakers: Myron S. Cohen (UNC School of Medicine), Chris Collins (amfAR, The Foundation for AIDS Research), Michele R. Decker (Johns Hopkins Bloomberg School of Public Health), Tim Horn (Treatment Action Group), Rick King (IAVI), Luiz Loures (UNAIDS), Mary A. Marovich (NIAID), Nelson L. Michael (Walter Reed Army Institute of Research), Julio Montaner (BC Centre for Excellence in HIV / AIDS), John P. Moore (Weill Cornell Medical College), Robert R. Redfield (University of Maryland School of Medicine), Bill Snow (Global HIV Vaccine Enterprise), Magdalena Sobieszczyk (Columbia University Medical Center), Annie Sparrow (Mount Sinai Global Health), Daniel Tietz (ACRIA), Mitchell Warren (AVAC), Jane Waterman (IAVI)
The UNAIDS "three zeros" strategy provides a clear vision for future HIV / AIDS research and policy. This symposium tackles communication and collaboration, capacity-building for HIV prevention, care, and treatment, vaccine trials and a case study.
Tuesday, April 30, 2013 | 7:00 PM - 8:30 PM
Ivan Oransky (Reuters Health), Harold Garner (Virginia Tech), Morton Meyers (SUNY Stony Brook)
From publish-or-perish to the race for ever-decreasing research dollars, scientists are under pressure to produce new scientific findings. Has the competitive culture of science gone too far? Join us as we try to unweave the web of scientific envy. Part of the Science and the Seven Deadly Sins Series.
Tuesday, February 12, 2013 | 6:30 PM - 8:00 PM
Brian Switek (Journalist), Danielle Lee (Oklahoma State University), Joshua Ginsberg (Wildlife Conservation Society), Stephanie Cacioppo (University of Chicago), Marina Cords (Columbia University)
Just in time for Valentine's Day, join the Academy as we explore lust and love in the animal kingdom. After learning about the love lives of creatures ranging from dinosaurs to bonobos, you'll be able to decide for yourself if you really want to call yourself an animal in bed. Part of the Science and the Seven Deadly Sins Series.
Organizers: Fritz François (New York University School of Medicine), Mekbib Gemeda (New York University Langone Medical Center), Jo Wiederhorn (Associated Medical Schools of New York), Sonya Dougal (The New York Academy of Sciences), and Brooke Grindlinger (The New York Academy of Sciences)
In this eBriefing, explore ways to incorporate health disparities research and preventative care approaches into the medical school curriculum, attract trainees to health inequity research, and improve the recruitment of minority medical students.
Speakers: Darrell R. Abernethy (U.S. Food and Drug Administration), Angela Birnbaum (University of Minnesota), Jenny Y. Chien (Eli Lilly and Company), Jeremy D. Walston (Johns Hopkins University School of Medicine), and Molly E. Zimmerman (Albert Einstein College of Medicine)
Organizers: Seongeun (Julia) Cho (U.S. Food and Drug Administration) and Jennifer Henry (The New York Academy of Sciences)
Older individuals are the major users of many medications, yet clinical data to support evidence-based therapy are often lacking. This eBriefing presents clinical, regulatory, and industry considerations in investigating drugs for older patients.
Speakers: Ole Isacson (McLean Hospital and Harvard Medical School), Marc Lalande (University of Connecticut Health Center) Sergiu P. Pasca (Stanford University School of Medicine), Hongjun Song (Johns Hopkins University), and Lorenz Studer (Memorial Sloan-Kettering Cancer Center)
Organizers: Mercedes Beyna (Pfizer), Susan DeLaura (Cellular Dynamics International, Inc.), Sandra Engle (Pfizer), Ken Jones (The Biochemical Pharmacology Discussion Group), and Jennifer Henry (The New York Academy of Sciences)
Induced pluripotent stem cells (iPSCs) offer a rare opportunity to study viable neurons potentially representative of the disease state. This eBriefing examines the generation of patient-specific iPSCs for experimental models, novel drug screening platforms, and perhaps in the future, cell-based therapies for major neurological diseases.
Moderator: W. Ian Lipkin (Columbia University)
Panelists: Arturo Casadevall (Albert Einstein College of Medicine; Member, NSABB), Laurie Garrett (Council on Foreign Relations), Barbara R. Jasny (Science
), Véronique Kiermer (Nature Publishing Group), Michael T. Osterholm (University of Minnesota; Member, NSABB), Peter Palese (Mount Sinai School of Medicine), Vincent Racaniello (Columbia University), and Alan S. Rudolph (Defense Threat Reduction Agency)
In this eBriefing, scientists, publishers, and legal experts explore the censorship and biosecurity issues surrounding the controversy over government recommendations that Nature and Science authors remove methodological details from papers describing their recent H5N1 studies.
Translational Medicine Initiative
The Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.
Learn more at www.nyas.org/TransMed.